AMAM News and Press, Ambrx Biopharma Inc. American Depositary Shares (each representing seven) From 02/13/23

Virtual presentation to take place on February 24, 2023 at 12:00pm ET Event will feature discussions regarding ARX788, Ambrx’s proprietary anti-HER2 targeting ADC, from key opinion leaders in breast cancer, Hope S. Rugo, M.D., FASCO, and Paula R. Pohlmann, M.D., M.S., Ph.D. Data up...

Ambrx Biopharma, Inc., or Ambrx (NYSE: AMAM), a clinical stage biopharmaceutical company using its proprietary Engineered Precision Biologics (EPBs) platform to create antibody-drug conjugates (ADCs), has appointed Sandra Aung, Ph.D., as Executive Vice President, Head of Clinical Development. Dr....

Summary Today, we put small developmental firm Ambrx Biopharma Inc. in the spotlight for the first time. This Busted IPO trades for less than the cash on its balance sheet and posted positive trial results in December. That said, the company had significant management turnover in 20...

If you’re looking for penny stocks to buy, short-squeeze stocks have gained some appeal in the stock market today. One of the primary reasons for this is the potential that some of these types of stock hold for incredible breakouts – and breakdowns, for that matter. While short sque...

Ambrx Biopharma Inc. (Ambrx) (NYSE: AMAM), a clinical stage biopharmaceutical company using its proprietary Engineered Precision Biologics platform to create antibody drug conjugates, announced today that it received a notice (the Notice) on November 23, 2022 from the New York Stock Exchange (NYS...

3 Ways to Find the Best Penny Stocks to Buy Investing in penny stocks can be an exciting and rewarding way to diversify your portfolio and potentially maximize your returns. With that said, it is important to know what you are getting into before investing in such speculative stocks. For that...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a topsy-turvy session today, investors may be intrigued by some of the biggest gainers and decliners as most stocks hold around the flat line. Among the leaders in terms of percentage gains today is biotech company  Amb...

AMAM Stock Explodes & Shed Light On Cheap Low Float Stocks One of the exciting things about penny stocks is that they can break out big even if the stock market is down. On top of that, it doesn’t take any significant catalyst to spark a rally. Many catalysts that trigger a ret...

​Ambrx Biopharma ( NYSE: AMAM ) reported preliminary data from a phase 2 trial of ARX788 in patients with HER2+ metastatic breast cancer who were previously treated with Roche's ( OTCQX:RHHBY ) ( OTCQX:RHHBF ) Kadcyla (trastuzumab emtansine) (T-DM1). ...

Data to be discussed in a Spotlight Poster Presentation at the 2022 San Antonio Breast Cancer Symposium Preliminary Phase 2 results from ACE-Breast-03 study demonstrate 57.1% confirmed overall response rate (ORR) by RECIST v1.1 and 100% disease control rate (DCR) in heavily pre-treated pa...